DUKORAL ORAL LIQUID (VACCINE) & EFFERVESCENT GRANULES, COMBINED PACK

Valsts: Malaizija

Valoda: angļu

Klimata pārmaiņas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Aktīvā sastāvdaļa:

V.CHOLERAE OGAWA 50 CLASSICAL BIOTYPE,; V.CHOLERAE OGAWA 50 CLASSICAL BIOTYPE,; RECOMBINANT CHOLERA TOXIN B SUBUNIT (RCTB-213); V.CHOLERAE INABA 48 CLASSICAL BIOTYPE,; V.CHOLERAE INABA 6973 EL TOR BIOTYPE,

Pieejams no:

AJ BIOLOGICS SDN. BHD.

SNN (starptautisko nepatentēto nosaukumu):

V.CHOLERAE OGAWA 50 CLASSICAL BIOTYPE,; V.CHOLERAE OGAWA 50 CLASSICAL BIOTYPE,; RECOMBINANT CHOLERA TOXIN B SUBUNIT (RCTB-213); V.CHOLERAE INABA 48 CLASSICAL BIOTYPE,; V.CHOLERAE INABA 6973 EL TOR BIOTYPE,

Vienības iepakojumā:

3ml1Units mL; 3ml100Units mL

Ražojis:

Valneva Sweden AB

Lietošanas instrukcija

PLEASE REFER TO PART I SECTION E12

Produkta apraksts

    
                       
 
 
   

       �